Advisor Group Holdings »

Contineum Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $78 6 13.00
2025-06-30 $70 10 7.00

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust State Street Spd (SPYM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)

View all positions for Advisor Group Holdings

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Sectoral Asset Management

View all funds holding Contineum Therapeutics